Anticholinergic burden and safety outcomes in older patients with chronic hepatitis C: A retrospective cohort study

Medicine and Dentistry

• Patient 100%
• Parasympatholytic 100%
• Retrospective Cohort Study 100%
• Chronic Hepatitis C 100%
• Drug Therapy 22%
• Antivirus Agent 18%
• Adverse Event 13%
• Inpatient 9%
• Health 4%
• Age 4%
• Prevalence 4%
• Health Outcomes 4%
• Combination Therapy 4%
• Cohort Effect 4%
• Infection 4%
• Predictor 4%
• Polypharmacy 4%
• Anticholinergic Effect 4%
• Medication 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Hepatitis C 100%
• Cholinergic Receptor Blocking Agent 100%
• Cohort Study 100%
• Antivirus Agent 18%
• Adverse Event 13%
• Observational Study 9%
• Epidemiology 4%
• Infection 4%
• Prevalence 4%
• Polypharmacy 4%
• Pharmacotherapy 4%

Psychology

• Hepatitis 100%
• Health 9%